Heterocyclic Iminoquinones and Quinones from the National Cancer Institute (NCI, USA) COMPARE Analysis
This review uses the National Cancer Institute (NCI) COMPARE program to establish an extensive list of heterocyclic iminoquinones and quinones with similarities in differential growth inhibition patterns across the 60-cell line panel of the NCI Developmental Therapeutics Program (DTP). Many natural...
Main Authors: | Naemah Haji, Masoma Faizi, Panayiotis A. Koutentis, Michael P. Carty, Fawaz Aldabbagh |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-07-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/28/13/5202 |
Similar Items
-
by: Asher Begleiter, et al.
Published: (2009-01-01) -
A Model for NAD(P)H:Quinoneoxidoreductase 1 (NQO1) Targeted Individualized Cancer Chemotherapy
by: Asher Begleiter, et al.
Published: (2009-01-01) -
NRF2 Activation by Nitrogen Heterocycles: A Review
by: Melford C. Egbujor, et al.
Published: (2023-03-01) -
Cancer Cell Sensitivity to Redox-Cycling Quinones is Influenced by NAD(P)H: Quinone Oxidoreductase 1 Polymorphism
by: Christophe Glorieux, et al.
Published: (2019-09-01) -
Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone
by: Yen-Chi Tsao, et al.
Published: (2020-06-01)